First-in-Class Drugs against ocular diseases
driven by hyper-vascularization and chronic inflammation
Revolutionizing severe retinal disease care with topical therapy & saving lives with groundbreaking treatments for uveal melanoma
Created in 2021 and located in Nice (France), Roca Therapeutics is a spin-off from Nice University and SATT Sud Est, incubated by the PACA-Est incubator.
Roca has an internationally recognized team of Directors and Advisors with a strong track record of Translational Research and Drug Development in Oncology, Ophtalmology and Immunology.
Roca Therapeutics is surrounded by several local and national strategic partners: IRCAN, ICN, Centre Antoine Lacassagne, CNRS, University Côte d’Azur, SATT Sud-Est, Canceropole PACA, Incubator Paca-Est, Eurobiomed, …
Roca Therapeutics has been rewarded by recognized prizes: i-Lab, bpifrance BFTE, PIA3, Amgen Prize, …
Roca Therapeutics is founded by a lead corporate VC and has been backed by several non-dilutive financings.
In October 2022, Roca Therapeutics completes seed funding round.
Our mission is to revolutionize eye care with innovative, non-invasive treatments, giving patients a brighter, clearer vision of life.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 112, Avenue Sainte-Marguerite, Nice,provence-Alpes-Côte D’azur 06200,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Cancer treatment, Eye disease, Angiogenesis, Inflammation, Drug development, Personalized therapy.
- HQ
- Nice, Provence-Alpes-Côte d’Azur
Roca Therapeutics Questions
Roca Therapeutics's website is https://www.roca-therapeutics.org
Roca Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/roca-therapeutics
Roca Therapeutics has
8 employees.
View email and phone details for 8
employees at Roca Therapeutics.
Roca Therapeutics's industry is
Biotechnology Research
Roca Therapeutics's top competitors are
Exadex-Innov,
Pulse Audition - Part Of Essilorluxottica,
Biper Therapeutics,
La Pousseraie,
Amkbiotech,
Kekkan Biologics,
G.clips Biotech,
Carla Biotherapeutics,
Landmark Bioventures Ag,
Elikya Therapeutics.
Roca Therapeutics's categories are Biotechnology Research
Roca Therapeutics's founding year is 2021
